Individual and Family Discount Dental Plans, Affordable
Dental Care Starting at $79.95 a Year!
1-888-632-5353 
M-F 8 AM - 9 PM EST 

Find Plans in Your Area
 
ZIP code
 

Find Dentists in Your Area
 
ZIP code
 
Dentist last name
(optional)
 




you are here: DentalPlans.com > Dental Health Articles > Cancer > Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer

Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer
Finding could help men with precancerous lesions avoid unnecessary needle biopsies
Updated: 5/2/2008 10:00:30 AM
 

FRIDAY, May 2 (HealthDay News) -- Spanish researchers report they may have found a way to tell which suspicious prostate lesions are likely to develop into cancer.

The findings, published in the May 1 issue of Clinical Cancer Research, show a link between high-grade prostatic intraepithelial neoplasia (HG-PIN) lesions and the PTOV1 gene. The more PTOV1 the lesion expresses, the more likely cancer will develop. The report also backs the reverse -- that the lack of PTOV1 means a reduced risk of prostate cancer.

PTOV1 is a protein that researchers don't fully understand the function of, but they have previously found too much of it appears to promote the spread of cancer cells.

If subsequent studies confirm PTOV1 as a biomarker for prostate cancer, it could help men with the lesions avoid repeated needle biopsies.

"Those patients with a high PTOV1 score should undergo an immediate repeat biopsy," study author Rosanna Paciucci, a researcher at the Vall d'Hebron Hospital Research Institute in Barcelona, said in a prepared statement. But those with low PTOVI may not need to receive future "annoying and useless" biopsies, she said. "We estimate that we can save 40 percent of unnecessary biopsies -- those that are repetitively negative and contain HG-PIN lesions that do not develop into cancer."

HG-PIN, while present in most cancerous prostates, is a pre-malignant lesion and, given its association with other cancers, it is often repeatedly biopsied when found. Past studies have put the average risk of cancer being diagnosed in a HG-PIN biopsy at between 20 percent and 30 percent, the researchers said. However, none of these studies were to tell which lesions would progress to cancer, the researchers say.

Paciucci cautioned that her team's results need to be confirmed through a larger study group. "From this validation, we can expect to improve the current rate of early detection of cancer," she said.

More information

The U.S. National Cancer Institute has more about prostate cancer.

-- Kevin McKeever

SOURCE: American Association for Cancer Research, news release, May 1, 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Customer Care - 1-888-632-5353 Toll Free

  
Additional Articles
Primary Tumors Fuel Growth of Cancer...
Facility Characteristics Influence...
DNA Coding May Make Bowel Prone to...
Raloxifene Cuts Risk of Certain Type of...
Researchers Update Risk-of-Death Charts
Medicare Costs for Cancer Treatment...
Decline in Cigarette Sales Offset by of...
Family History Plays Role in Black...
Blood Cancer Drug Shows Promise Against...
Method for Treating Cervical Lesions...
Fruits, Vegetables, Teas May Cut Risk...
Diabetes Boosts Liver Cancer Risk in...
Family History Might Improve Odds Colon...
Androgen Production Continues in Cancer...
Dangerous Side Effect Found in Cancer...
Chronic Stomach Inflammation Boosts...
Smokers With Colon Cancer Face High...
Black Cancer Patients Choose More Care...
Vaccine May Boost Survival of Brain...
U.S. Childhood Cancers Vary by Sex,...
3-Drug Combo Improves Advanced Cancer...
Erbitux Works Well for Two-Thirds of...
Anemia Drugs May Speed Tumor Growth in...
Combo Therapy Knocks Out Melanoma...
Celebrex May Reduce Levels of Lung...
Acupuncture Eases Side Effects of Head,...
Young Hodgkin Survivors Face Later Risk...
Erbitux Plus Chemo Improves Lung Cancer...
New Hope for Tough-to-Treat Cancers
Hodgkin Lymphoma Kids Face Greater Risk...
Avastin Added to Chemo Helps Women With...
Avastin Added to Chemo Helps Women With...
Bone Drug Lowers Risk of Breast Cancer...
Chemo May Limit Fertility in Breast...
Certain Tests in ERs Raise Cancer Risk...
Initiative Links Celebrities to Cancer...
Type of Tomato Product Determines Power...
Paclitaxel Plus Chemo Improves Outcomes...
Cancer Patients Should Steer Clear of...
Common Genetic Variant Tied to Lung...

Add to Google MSN Cancer
 Add Cancer
 To My Yahoo  Subscribe with Bloglines   Subscribe in NewsGator Online Cancer
 News Feed

The materials and articles published on DentalPlans.com are for informational purposes only. Although DentalPlans.com strives to be accurate and complete, the information is provided without liability for errors. DentalPlans.com does not warrant the accuracy or completeness of the information, text graphics, links, or other items contained on DentalPlans.com.

DentalPlans.com expressly disclaims liability for errors or omissions in these materials and DentalPlans.com makes no commitment to update the information on DentalPlans.com.

DentalPlans.com expressly disclaims all liability for the use or interpretation by others of information on DentalPlans.com. Decisions based on information contained on DentalPlans.com are the sole responsibility of the visitors, and visitors agree to hold DentalPlans.com and its Affiliates harmless against any claims for damages arising from decisions visitors make on such information.

Nothing on DentalPlans.com constitutes medical advice or other forms of advice. DentalPlans.com assumes no responsibility for material created or published by third parties linked to DentalPlans.com with or without DentalPlans.coms knowledge.

Let's Get Connected
Like Us on Facebook Follow Us on Twitter DentalPlans.com Blog, Dental Insurance Alternatives View Our YouTube Channel
Email Me Savings & Updates
Submit
Privacy Policy
The DENTALPLANS.COM website is administered by DENTALPLANS.COM, INC., a licensed Florida Discount Medical Plan Organization, 8100 S.W. 10th Street Suite #2000, Plantation, FL 33324. Plans and Programs offered by DentalPlans.com are not health insurance policies. Plans and Programs offered by DentalPlans.com provide discounts at certain health care providers for medical services. Plans and Programs offered by DentalPlans.com do not make payments directly to the providers of medical services. The Plan or Program member is obligated to pay for all health care services but will receive a discount from those health care providers who have contracted with the Plan, Program or discount plan organization.
Special promotions including but not limited to additional months free and Membership Rewards® points from American Express are not available to California residents.

© 1999-2011 DentalPlans.com, Inc. All Rights Reserved. Patents Pending. Blue Cross and Blue Shield of Florida is an Independent Licensee of the Blue Cross and Blue Shield Association.
BBB Rating A+    McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams